{"transactions":[{"id":707735,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2026-07-18T01:50:26.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":78700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant."}],"balance_after":78700,"derivative":{"exercise_price":0.5149,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":78700},"source":{"system":"sec-edgar","filing":"0001437749-26-023809","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926023809/rdgdoc.xml","form_type":"4"}},{"id":707734,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-18T01:50:26.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":39400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant."}],"balance_after":135966,"source":{"system":"sec-edgar","filing":"0001437749-26-023809","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926023809/rdgdoc.xml","form_type":"4"}},{"id":739489,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:06:33.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest upon the earlier of (i) the first anniversary of the grant date or (ii) the date of the Issuer's next annual meeting of stockholders following the grant date, subject in each case to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":3000,"derivative":{"exercise_price":102.19,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-26-073437","document":"tm2617372-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235471/000110465926073437/tm2617372-4_4seq1.xml","form_type":"4"}},{"id":873792,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-02T13:00:10.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":2400,"price":125,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased in the underwritten offering of Palvella Therapeutics, Inc. at the offering price, which closed on February 27, 2026."}],"balance_after":47812,"source":{"system":"sec-edgar","filing":"0001104659-26-021921","document":"tm267613-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235471/000110465926021921/tm267613-1_4seq1.xml","form_type":"4"}},{"id":992083,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-21T18:21:51.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":16783,"price":0.405,"value":6797.115,"ownership":{"direct":true},"balance_after":96566,"source":{"system":"sec-edgar","filing":"0001437749-25-035952","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925035952/rdgdoc.xml","form_type":"4"}},{"id":992082,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-21T18:21:51.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":23217,"price":0.393,"value":9124.281,"ownership":{"direct":true},"balance_after":79783,"source":{"system":"sec-edgar","filing":"0001437749-25-035952","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925035952/rdgdoc.xml","form_type":"4"}},{"id":1110639,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T01:04:33.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":95400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary of the date of the grant."}],"balance_after":95400,"derivative":{"exercise_price":0.7,"expiration_date":"2035-06-13","underlying":"Common Stock","underlying_shares":95400},"source":{"system":"sec-edgar","filing":"0001437749-25-020570","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925020570/rdgdoc.xml","form_type":"4"}},{"id":1110638,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T01:04:33.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary date of the grant."}],"balance_after":56566,"source":{"system":"sec-edgar","filing":"0001437749-25-020570","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925020570/rdgdoc.xml","form_type":"4"}},{"id":1114737,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-11T23:59:36.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12350,"derivative":{"exercise_price":26.23,"exercise_date":"2026-06-10","expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":12350},"source":{"system":"sec-edgar","filing":"0001583648-25-000039","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235471/000158364825000039/edgardoc.xml","form_type":"4"}},{"id":1328332,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-18T01:46:08.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":24700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest and become exercisable in 36 equal monthly installments through the third anniversary of the grant date."}],"balance_after":24700,"derivative":{"exercise_price":13.6,"expiration_date":"2034-12-13","underlying":"Common Stock","underlying_shares":24700},"source":{"system":"sec-edgar","filing":"0001062993-24-020823","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235471/000106299324020823/form4.xml","form_type":"4"}},{"id":1482726,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T20:39:43.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":95400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary of the date of the grant."}],"balance_after":95400,"derivative":{"exercise_price":0.77,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":95400},"source":{"system":"sec-edgar","filing":"0001437749-24-020096","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924020096/rdgdoc.xml","form_type":"4"}},{"id":1482725,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-12T20:39:43.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary date of the grant."}],"balance_after":40566,"source":{"system":"sec-edgar","filing":"0001437749-24-020096","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924020096/rdgdoc.xml","form_type":"4"}},{"id":1493197,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-06-04T23:29:46.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":5047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":63.1,"exercise_date":"2014-09-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":5047},"source":{"system":"sec-edgar","filing":"0001048477-24-000118","document":"wk-form4_1717543778.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000118/wk-form4_1717543778.xml","form_type":"4"}},{"id":1493196,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T23:29:46.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4168,"price":76.41,"value":318476.88,"ownership":{"direct":true},"balance_after":97720,"source":{"system":"sec-edgar","filing":"0001048477-24-000118","document":"wk-form4_1717543778.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000118/wk-form4_1717543778.xml","form_type":"4"}},{"id":1493195,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T23:29:46.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":5047,"price":63.1,"value":318465.7,"ownership":{"direct":true},"balance_after":101888,"source":{"system":"sec-edgar","filing":"0001048477-24-000118","document":"wk-form4_1717543778.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000118/wk-form4_1717543778.xml","form_type":"4"}},{"id":1504167,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T21:26:21.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":4720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 21, 2024. Price not applicable."}],"balance_after":96841,"source":{"system":"sec-edgar","filing":"0001048477-24-000102","document":"wk-form4_1716499557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000102/wk-form4_1716499557.xml","form_type":"4"}},{"id":1820095,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-08-02T01:20:59.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":41510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary of the date of the grant."}],"balance_after":41510,"derivative":{"exercise_price":0.74,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":41510},"source":{"system":"sec-edgar","filing":"0001437749-23-021505","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923021505/rdgdoc.xml","form_type":"4"}},{"id":1820094,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-02T01:20:59.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":6922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary date of the grant."}],"balance_after":24566,"source":{"system":"sec-edgar","filing":"0001437749-23-021505","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923021505/rdgdoc.xml","form_type":"4"}},{"id":1880114,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T22:25:25.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":4190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 23, 2023. Price not applicable."}],"balance_after":92121,"source":{"system":"sec-edgar","filing":"0001209191-23-031968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123031968/doc4.xml","form_type":"4"}},{"id":1889782,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-05-17T22:14:24.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-08-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-23-030367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030367/doc4.xml","form_type":"4"}},{"id":1889781,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T22:14:24.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":6137,"price":93.93,"value":576448.41,"ownership":{"direct":true},"balance_after":87931,"source":{"system":"sec-edgar","filing":"0001209191-23-030367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030367/doc4.xml","form_type":"4"}},{"id":1889780,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T22:14:24.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":true,"shares":8500,"price":67.81,"value":576385.0,"ownership":{"direct":true},"balance_after":94068,"source":{"system":"sec-edgar","filing":"0001209191-23-030367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030367/doc4.xml","form_type":"4"}},{"id":2174561,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-08-25T21:06:33.000Z","date":"2022-08-25","kind":"grant","acquired":true,"shares":88448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest annually over three years from the vesting commencement date of August 25, 2022, the date of the grantee's appointment as a director of Vaxart, Inc."}],"balance_after":88448,"derivative":{"exercise_price":3.36,"expiration_date":"2032-08-24","underlying":"Common Stock","underlying_shares":88448},"source":{"system":"sec-edgar","filing":"0001437749-22-021354","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922021354/rdgdoc.xml","form_type":"4"}},{"id":2174560,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-08-25T21:06:33.000Z","date":"2022-08-25","kind":"grant","acquired":true,"shares":14750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. One third of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the third anniversary of the grant date."}],"balance_after":17644,"source":{"system":"sec-edgar","filing":"0001437749-22-021354","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922021354/rdgdoc.xml","form_type":"4"}},{"id":2255592,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T00:45:09.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":4980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 24, 2022.  Price not applicable."}],"balance_after":85568,"source":{"system":"sec-edgar","filing":"0001567619-22-011790","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922011790/doc1.xml","form_type":"4"}},{"id":2369637,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-03-01T02:52:45.000Z","date":"2022-02-25","kind":"exercise","acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":37.46,"exercise_date":"2012-11-08","expiration_date":"2022-05-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001567619-22-005823","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922005823/doc1.xml","form_type":"4"}},{"id":2369636,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T02:52:45.000Z","date":"2022-02-25","kind":"exercise","acquired":true,"shares":8500,"price":37.46,"value":318410.0,"ownership":{"direct":true},"balance_after":80588,"source":{"system":"sec-edgar","filing":"0001567619-22-005823","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922005823/doc1.xml","form_type":"4"}},{"id":2693919,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T21:37:32.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":5120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 25, 2021.  Price not applicable."}],"balance_after":72088,"source":{"system":"sec-edgar","filing":"0001567619-21-011303","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921011303/doc1.xml","form_type":"4"}},{"id":3010237,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-10-09T00:35:01.000Z","date":"2020-10-07","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":26.49,"exercise_date":"2011-11-12","expiration_date":"2021-05-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-20-017700","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920017700/doc1.xml","form_type":"4"}},{"id":3010236,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-09T00:35:01.000Z","date":"2020-10-07","kind":"exercise","acquired":true,"shares":15000,"price":26.49,"value":397350.0,"ownership":{"direct":true},"balance_after":66968,"source":{"system":"sec-edgar","filing":"0001567619-20-017700","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920017700/doc1.xml","form_type":"4"}},{"id":3131038,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T20:50:07.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 27, 2020. Price not applicable."}],"balance_after":51968,"source":{"system":"sec-edgar","filing":"0001567619-20-011358","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920011358/doc1.xml","form_type":"4"}},{"id":3443853,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2019-08-08T23:34:23.000Z","date":"2019-08-07","kind":"exercise","acquired":false,"shares":1553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":5047,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":1553},"source":{"system":"sec-edgar","filing":"0001567619-19-016093","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919016093/doc1.xml","form_type":"4"}},{"id":3443852,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-08T23:34:23.000Z","date":"2019-08-07","kind":"exercise","acquired":true,"shares":1553,"price":63.1,"value":97994.3,"ownership":{"direct":true},"balance_after":47668,"source":{"system":"sec-edgar","filing":"0001567619-19-016093","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919016093/doc1.xml","form_type":"4"}},{"id":3499215,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T22:10:39.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":4430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 4, 2019. Price not applicable."}],"balance_after":46115,"source":{"system":"sec-edgar","filing":"0001567619-19-012973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919012973/doc1.xml","form_type":"4"}},{"id":3822465,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-07T18:00:59.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":1000,"price":96.935,"value":96935.0,"ownership":{"direct":true},"balance_after":41685,"source":{"system":"sec-edgar","filing":"0001567619-18-002256","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002256/doc1.xml","form_type":"4"}},{"id":3902157,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T00:22:45.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 5, 2018. Price not applicable."}],"balance_after":42685,"source":{"system":"sec-edgar","filing":"0001140361-18-027787","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118027787/doc1.xml","form_type":"4"}},{"id":4128924,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-19T01:56:46.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":800,"price":88.895,"value":71116.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All shares sold at the same price."}],"balance_after":38385,"source":{"system":"sec-edgar","filing":"0001140361-17-046612","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117046612/doc1.xml","form_type":"4"}},{"id":4288681,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy) Common Stock","published_at":"2017-06-08T22:23:35.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":4910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests in full on June 6, 2018."}],"balance_after":4910,"derivative":{"exercise_price":89.6,"exercise_date":"2018-06-06","expiration_date":"2027-06-05","underlying":"Common Stock","underlying_shares":4910},"source":{"system":"sec-edgar","filing":"0001140361-17-024504","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117024504/doc1.xml","form_type":"4"}},{"id":4288680,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":29983,"kind":"person","name":"HERON ELAINE J","position":1,"cik":"0001235471","reported_name":"HERON ELAINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-08T22:23:35.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":2050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 6, 2017.  Price not applicable."}],"balance_after":39185,"source":{"system":"sec-edgar","filing":"0001140361-17-024504","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117024504/doc1.xml","form_type":"4"}}]}